Jae Hong Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jae Hong Lee has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
- Jae Gun Kwak
Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
9 shared publications - Woong-Han Kim
Department of Thoracic and Cardiovascular Surgery, Seoul National University Children’s Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
9 shared publications - Hye Won Kwon
Department of Thoracic and Cardiovascular Surgery, Seoul National University Children’s Hospital , Seoul 03080
7 shared publications - Sungkyu Cho
Department of Thoracic and Cardiovascular Surgery, Seoul National University Children’s Hospital, Seoul, Korea
7 shared publications - Chan Hyeong Kim
Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul, Republic of Korea
3 shared publications - Hyungtae Kim
Department of Thoracic and Cardiovascular Surgery, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, School of Medicine, Pusan National University, Yangsan, Korea
2 shared publications
Latest Publications
- Open Access
- 31 August 2026
- Published by The Korean Society of Critical Care Medicine in Acute and Critical Care
- Vol. 41 (3) , 654-660
Vasoactive-inotropic score as a predictor of clinical deterioration in pediatric patients undergoing venovenous extracorporeal membrane oxygenation: a preliminary single-center study in South Korea
Background: Venovenous (VV) extracorporeal membrane oxygenation (ECMO) supports pediatric patients with severe respiratory failure; however, some experience clinical deterioration requiring conversion to venoarterial (VA) ECMO or resulting in mortality. The prognostic role of the vasoactive-inotropic score (VIS) at VV ECMO cannulation remains unclear.Methods: We retrospectively analyzed pediatric patients who underwent VV ECMO between 2010 and 2024 at a single center. Baseline VIS was calculated from vasoactive infusion rates documented immediately prior to cannulation. The primary composite outcome was conversion to VA ECMO or in-hospital mortality. Associations between VIS and outcomes were assessed using correlation, univariable logistic regression, and receiver operating characteristic (ROC) analysis.Results: Twenty patients underwent VV ECMO. Five (25.0%) required VA conversion, seven (35.0%) died, and nine (45.0%) met the composite outcome. Baseline VIS was not significantly associated with isolated mode change (r=0.13, P=0.589) and showed a borderline association with mortality (r=0.43, P=0.062). Logistic regression demonstrated a consistent direction of association between higher baseline VIS and the composite outcome (odds ratio, 1.04; 95% CI, 1.00–1.09; P=0.078). Correlation analysis also suggested an association (r=0.54, P=0.014). ROC analysis demonstrated an AUC of 0.79, suggesting potential discriminative ability, with an exploratory cutoff of 25.Conclusions: Baseline VIS showed a possible association with clinical deterioration in this pilot cohort. These findings are exploratory and require validation in larger prospective multicenter studies.
- 31 August 2026
- Published by The Korean Society of Critical Care Medicine in Acute and Critical Care
- Vol. 41 (3) , 654-660
Open AccessVasoactive-inotropic score as a predictor of clinical deterioration in pediatric patients undergoing venovenous extracorporeal membrane oxygenation: a preliminary single-center study in South Korea
Background: Venovenous (VV) extracorporeal membrane oxygenation (ECMO) supports pediatric patients with severe respiratory failure; however, some experience clinical deterioration requiring conversion to venoarterial (VA) ECMO or resulting in mortality. The prognostic role of the vasoactive-inotropic score (VIS) at VV ECMO cannulation remains unclear.Methods: We retrospectively analyzed pediatric patients who underwent VV ECMO between 2010 and 2024 at a single center. Baseline VIS was calculated from vasoactive infusion rates documented immediately prior to cannulation. The primary composite outcome was conversion to VA ECMO or in-hospital mortality. Associations between VIS and outcomes were assessed using correlation, univariable logistic regression, and receiver operating characteristic (ROC) analysis.Results: Twenty patients underwent VV ECMO. Five (25.0%) required VA conversion, seven (35.0%) died, and nine (45.0%) met the composite outcome. Baseline VIS was not significantly associated with isolated mode change (r=0.13, P=0.589) and showed a borderline association with mortality (r=0.43, P=0.062). Logistic regression demonstrated a consistent direction of association between higher baseline VIS and the composite outcome (odds ratio, 1.04; 95% CI, 1.00–1.09; P=0.078). Correlation analysis also suggested an association (r=0.54, P=0.014). ROC analysis demonstrated an AUC of 0.79, suggesting potential discriminative ability, with an exploratory cutoff of 25.Conclusions: Baseline VIS showed a possible association with clinical deterioration in this pilot cohort. These findings are exploratory and require validation in larger prospective multicenter studies.
- 9 July 2026
- Published by Springer Nature in Pediatric Cardiology
- p. 1-8
Long-Term Fate of the Systemic Right Ventricle: In Patients with Bi-ventricle Versus Single Ventricle
The unique anatomical and physiological characteristics of the systemic right ventricle (sRV) raise prognostic concerns. This study aimed to characterize its long-term clinical course and identify risk factors for adverse outcomes. Patients with sRV who underwent biventricle (BiV) repair or Fontan procedure between January 2000 and July 2023 were reviewed. Comparative analysis between patients with BiV status and single ventricle (SV), and risk factor analysis were performed for long-term outcomes including overall survival and adverse outcomes. In total, 141 patients with sRV (median age 3.1 years (interquartile range (IQR) 2.5–3.8), male 63.1%) were enrolled, with 117 patients (83.0%) undergoing Fontan procedure and 24 patients (17.0%) undergoing BiV repair. Median follow-up duration was 14.3 years (IQR 5.9–18.5). There were no significant differences between BiV and SV in overall survival, composite endpoint for heart failure, percutaneous intervention and major arrhythmia events. BiV showed significantly higher cumulative incidence of re-operation (5-, 10-, 15-year cumulative incidence: 0.340, 0.449, 0.449 vs. 0.136, 0.178, 0.178, p = 0.011) and tricuspid valve surgery (5-, 10-, 15-year cumulative incidence: 0.217, 0.402, 0.402 vs. 0.009, 0.031, 0.031, 0.031, p < 0.001). Multivariable risk factor analysis identified BiV as a significant risk factor for re-operation (subdistribution hazards ratio (sHR) 2.759, 95% confidence interval (CI) 1.028–7.407, p = 0.044) and tricuspid valve surgery (sHR 13.709, 95% CI 1.176-166.667, p = 0.037). sRV, both in SV or BiV circulation, showed good adaptability and tolerable early long-term performance. The follow-up of patients with a sRV requires careful consideration of disease-specific differences and the adoption of individualized surveillance strategies for each condition.
- 9 July 2026
- Published by Springer Nature in Pediatric Cardiology
- p. 1-8
Long-Term Fate of the Systemic Right Ventricle: In Patients with Bi-ventricle Versus Single Ventricle
The unique anatomical and physiological characteristics of the systemic right ventricle (sRV) raise prognostic concerns. This study aimed to characterize its long-term clinical course and identify risk factors for adverse outcomes. Patients with sRV who underwent biventricle (BiV) repair or Fontan procedure between January 2000 and July 2023 were reviewed. Comparative analysis between patients with BiV status and single ventricle (SV), and risk factor analysis were performed for long-term outcomes including overall survival and adverse outcomes. In total, 141 patients with sRV (median age 3.1 years (interquartile range (IQR) 2.5–3.8), male 63.1%) were enrolled, with 117 patients (83.0%) undergoing Fontan procedure and 24 patients (17.0%) undergoing BiV repair. Median follow-up duration was 14.3 years (IQR 5.9–18.5). There were no significant differences between BiV and SV in overall survival, composite endpoint for heart failure, percutaneous intervention and major arrhythmia events. BiV showed significantly higher cumulative incidence of re-operation (5-, 10-, 15-year cumulative incidence: 0.340, 0.449, 0.449 vs. 0.136, 0.178, 0.178, p = 0.011) and tricuspid valve surgery (5-, 10-, 15-year cumulative incidence: 0.217, 0.402, 0.402 vs. 0.009, 0.031, 0.031, 0.031, p < 0.001). Multivariable risk factor analysis identified BiV as a significant risk factor for re-operation (subdistribution hazards ratio (sHR) 2.759, 95% confidence interval (CI) 1.028–7.407, p = 0.044) and tricuspid valve surgery (sHR 13.709, 95% CI 1.176-166.667, p = 0.037). sRV, both in SV or BiV circulation, showed good adaptability and tolerable early long-term performance. The follow-up of patients with a sRV requires careful consideration of disease-specific differences and the adoption of individualized surveillance strategies for each condition.
- Open Access
- 25 May 2026
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 41 (6)
Cone Reconstruction for Ebstein Anomaly: Effect on Tricuspid Valve Growth and Biventricular Remodelling in Children
Objectives: This study aimed to evaluate the surgical outcomes of cone reconstruction (CR) in paediatric patients with Ebstein anomaly (EA). Methods: We retrospectively reviewed seventeen paediatric patients (<18 years) with EA (Carpentier types A, B, and C in 3, 12, and 2, respectively) who underwent CR without prosthetic annuloplasty materials between January 2014 and December 2024. Clinical outcomes, including tricuspid valve (TV) and biventricular function and size, were evaluated using echocardiography and cardiac magnetic resonance imaging (CMR). Results: The median age and body weight at surgery were 7.8 years and 21.2 kg, respectively. No operative mortality occurred; however, 3 patients required permanent pacemaker implantation before discharge. No late deaths, reoperations, or significant tricuspid regurgitation (TR, ≥moderate) or stenosis (mean pressure gradient ≥5 mmHg) occurred during the 8.2-year median follow-up. TR was significantly reduced postoperatively (odds ratio 1.34, 95% CI, 1.10-1.64, P = .008) and remained stable without recurrence of significant TR during follow-up. The mean TV annulus z-score decreased significantly after CR (1.81 [1.19] preoperatively versus −1.74 [0.92] at discharge, mean difference: −3.55, 95% CI, −4.30 to −2.80, P < .001) and remained within the normal range during follow-up (−1.74 [0.92] at discharge versus −1.61 [1.11] at the last follow-up, mean difference: 0.04, 95% CI, −0.02-0.10, P = .207). Postoperative CMR demonstrated significantly reduced TR fraction and right heart volumetric parameters, except functional right ventricular end-systolic volume and pulmonary forward flow volume indices. Based on CMR, left ventricular end-diastolic (change 2.40, 95% CI, 0.52-4.27, P = .014) and systolic (change 1.75, 95% CI, 0.74-2.76, P = .002) volume indices significantly increased over time. Conclusions: Long-term outcomes after CR without prosthetic annuloplasty materials were favourable in paediatric patients with EA. CR can achieve durable reduction of TR with sustained TV growth, potentially facilitating biventricular reverse remodelling.
- 25 May 2026
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 41 (6)
Open AccessCone Reconstruction for Ebstein Anomaly: Effect on Tricuspid Valve Growth and Biventricular Remodelling in Children
Objectives: This study aimed to evaluate the surgical outcomes of cone reconstruction (CR) in paediatric patients with Ebstein anomaly (EA). Methods: We retrospectively reviewed seventeen paediatric patients (<18 years) with EA (Carpentier types A, B, and C in 3, 12, and 2, respectively) who underwent CR without prosthetic annuloplasty materials between January 2014 and December 2024. Clinical outcomes, including tricuspid valve (TV) and biventricular function and size, were evaluated using echocardiography and cardiac magnetic resonance imaging (CMR). Results: The median age and body weight at surgery were 7.8 years and 21.2 kg, respectively. No operative mortality occurred; however, 3 patients required permanent pacemaker implantation before discharge. No late deaths, reoperations, or significant tricuspid regurgitation (TR, ≥moderate) or stenosis (mean pressure gradient ≥5 mmHg) occurred during the 8.2-year median follow-up. TR was significantly reduced postoperatively (odds ratio 1.34, 95% CI, 1.10-1.64, P = .008) and remained stable without recurrence of significant TR during follow-up. The mean TV annulus z-score decreased significantly after CR (1.81 [1.19] preoperatively versus −1.74 [0.92] at discharge, mean difference: −3.55, 95% CI, −4.30 to −2.80, P < .001) and remained within the normal range during follow-up (−1.74 [0.92] at discharge versus −1.61 [1.11] at the last follow-up, mean difference: 0.04, 95% CI, −0.02-0.10, P = .207). Postoperative CMR demonstrated significantly reduced TR fraction and right heart volumetric parameters, except functional right ventricular end-systolic volume and pulmonary forward flow volume indices. Based on CMR, left ventricular end-diastolic (change 2.40, 95% CI, 0.52-4.27, P = .014) and systolic (change 1.75, 95% CI, 0.74-2.76, P = .002) volume indices significantly increased over time. Conclusions: Long-term outcomes after CR without prosthetic annuloplasty materials were favourable in paediatric patients with EA. CR can achieve durable reduction of TR with sustained TV growth, potentially facilitating biventricular reverse remodelling.
- Open Access
- 1 January 2026
- Published by XMLink in Korean Circulation Journal
- Vol. 56 (3) , 250-265
Long-term Outcomes of Standardized Strategy in Arterial Switch Operation: An 18-Year Review in a Single Center
Lee JH, et al. Korean Circ J. 2025 Sep;56:e12. https://doi.org/10.4070/kcj.2025.0035
- 1 January 2026
- Published by XMLink in Korean Circulation Journal
- Vol. 56 (3) , 250-265
Open AccessLong-term Outcomes of Standardized Strategy in Arterial Switch Operation: An 18-Year Review in a Single Center
Lee JH, et al. Korean Circ J. 2025 Sep;56:e12. https://doi.org/10.4070/kcj.2025.0035
- Open Access
- 19 March 2025
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 40 (3)
Role of tricuspid valve repair in pulmonary atresia with intact ventricular septum: fresh autologous pericardium as a viable option
OBJECTIVES: This study aimed to evaluate the surgical outcomes of tricuspid valve (TV) leaflet augmentation using fresh autologous pericardium (FAP) in patients with pulmonary atresia with intact ventricular septum (PA-IVS). METHODS: Nine patients with PA-IVS underwent TV leaflet augmentation (TVLA) using FAP between January 2017 and April 2024. Native TV failure (NTVF) was defined as significant (≥moderate) tricuspid regurgitation and/or stenosis (mean pressure gradient> 5 mmHg). Clinical outcomes including both TV and right ventricle (RV) size and functions were evaluated using echocardiography and magnetic resonance imaging (MRI). RESULTS: The median age and body weight at the time of surgery were 5.4 years and 21.2 kg, respectively. No operative mortality occurred. During the follow-up period, no late mortalities, reoperations, or significant TV leaflet-related complications were observed; NTVF was not observed in any patients, except one with significant tricuspid regurgitation. Biventricular repair was performed in all patients except one who had undergone preoperative one-and-a-half ventricle repair. After TVLA using FAP, the median TV annulus z-score remained within the normal ranges (preoperative -0.42[-0.62 to 0.57] vs postoperative -0.51[-0.95 to -0.13], mean difference: 0.231, 95% confidence interval: -0.338 to 0.800, p = 0.377) and tricuspid regurgitation improved significantly (mean difference: 2.111, 95% confidence interval: 1.510–2.712, p = 0.040). Postoperative MRI showed that RV function and cardiac output were preserved within acceptable ranges. CONCLUSIONS: TVLA using FAP could be a considerable and viable approach to optimize RV growth while preserving RV and TV functions in the long-term in young patients with PA-IVS.
- 19 March 2025
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 40 (3)
Open AccessRole of tricuspid valve repair in pulmonary atresia with intact ventricular septum: fresh autologous pericardium as a viable option
OBJECTIVES: This study aimed to evaluate the surgical outcomes of tricuspid valve (TV) leaflet augmentation using fresh autologous pericardium (FAP) in patients with pulmonary atresia with intact ventricular septum (PA-IVS). METHODS: Nine patients with PA-IVS underwent TV leaflet augmentation (TVLA) using FAP between January 2017 and April 2024. Native TV failure (NTVF) was defined as significant (≥moderate) tricuspid regurgitation and/or stenosis (mean pressure gradient> 5 mmHg). Clinical outcomes including both TV and right ventricle (RV) size and functions were evaluated using echocardiography and magnetic resonance imaging (MRI). RESULTS: The median age and body weight at the time of surgery were 5.4 years and 21.2 kg, respectively. No operative mortality occurred. During the follow-up period, no late mortalities, reoperations, or significant TV leaflet-related complications were observed; NTVF was not observed in any patients, except one with significant tricuspid regurgitation. Biventricular repair was performed in all patients except one who had undergone preoperative one-and-a-half ventricle repair. After TVLA using FAP, the median TV annulus z-score remained within the normal ranges (preoperative -0.42[-0.62 to 0.57] vs postoperative -0.51[-0.95 to -0.13], mean difference: 0.231, 95% confidence interval: -0.338 to 0.800, p = 0.377) and tricuspid regurgitation improved significantly (mean difference: 2.111, 95% confidence interval: 1.510–2.712, p = 0.040). Postoperative MRI showed that RV function and cardiac output were preserved within acceptable ranges. CONCLUSIONS: TVLA using FAP could be a considerable and viable approach to optimize RV growth while preserving RV and TV functions in the long-term in young patients with PA-IVS.
- Open Access
- 1 March 2024
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 38 (3)
Outcomes of not using tracheoplasty in asymptomatic tracheal stenosis found during open-heart surgery
We aimed to review the outcomes of treating incidentally encountered asymptomatic airway stenosis during open-heart surgery conservatively without the use of tracheoplasty. Between January 2002 and October 2022, 25 patients were incidentally diagnosed with tracheal stenosis during open-heart surgery. Intraoperative bronchoscopy and/or laryngoscopy revealed tracheal stenosis; however, this was not consistent with the findings of the preoperative computed tomography. Patients who were diagnosed with a pulmonary artery or vascular sling or had moderate-to-severe respiratory symptoms before open-heart surgery were excluded. The median age and weight of the patients at operation were 3.0 months and 5.1 kg, respectively. They were categorized as those having tracheal stenosis on preoperative computed tomography (n = 12) or not having tracheal stenosis (n = 13). The narrowest diameter was significantly smaller in the former group (3.0 vs 5.8 mm, P < 0.05). The rates of reintubation and the tracheostomy, and intubation days tended to be higher in former group without statistical significance. Stenotic degree improved 2 months and 1 year or more after the operation (39.3% at operation, 28.4% at 2 months, 12.5% after 1 year). All patients were Ross class 1 or 2 at follow-up (mean, 7.1 years). Patients with tracheal stenosis showed tolerable long-term outcomes without using tracheoplasty. Accordingly, if tracheal stenosis, that would cause intubation difficulty, was incidentally revealed, concomitant tracheoplasty may not be required during open-heart surgery if the stenosis did not cause considerable symptoms or signs preoperatively.
- 1 March 2024
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 38 (3)
Open AccessOutcomes of not using tracheoplasty in asymptomatic tracheal stenosis found during open-heart surgery
We aimed to review the outcomes of treating incidentally encountered asymptomatic airway stenosis during open-heart surgery conservatively without the use of tracheoplasty. Between January 2002 and October 2022, 25 patients were incidentally diagnosed with tracheal stenosis during open-heart surgery. Intraoperative bronchoscopy and/or laryngoscopy revealed tracheal stenosis; however, this was not consistent with the findings of the preoperative computed tomography. Patients who were diagnosed with a pulmonary artery or vascular sling or had moderate-to-severe respiratory symptoms before open-heart surgery were excluded. The median age and weight of the patients at operation were 3.0 months and 5.1 kg, respectively. They were categorized as those having tracheal stenosis on preoperative computed tomography (n = 12) or not having tracheal stenosis (n = 13). The narrowest diameter was significantly smaller in the former group (3.0 vs 5.8 mm, P < 0.05). The rates of reintubation and the tracheostomy, and intubation days tended to be higher in former group without statistical significance. Stenotic degree improved 2 months and 1 year or more after the operation (39.3% at operation, 28.4% at 2 months, 12.5% after 1 year). All patients were Ross class 1 or 2 at follow-up (mean, 7.1 years). Patients with tracheal stenosis showed tolerable long-term outcomes without using tracheoplasty. Accordingly, if tracheal stenosis, that would cause intubation difficulty, was incidentally revealed, concomitant tracheoplasty may not be required during open-heart surgery if the stenosis did not cause considerable symptoms or signs preoperatively.
- 20 November 2023
- Published by Wiley in Pediatric Transplantation
- Vol. 28 (1) , e14656
Right lower lung midline herniation as a rare complication in an infant with heart–lung transplantation: A case report
Background: Lung herniation is a rare complication of heart–lung transplantation that can be fatal owing to vascular compromise and airway obstruction. To date, only five cases of lung herniation related to heart–lung transplantation have been reported in the literature; however, to the best of our knowledge, this is the first worldwide report of heart–lung transplantation‐related lung herniation in an infant.Methods: We describe the case of lung herniation as a rare heart–lung transplantation‐related complication in an infant. A 12‐month‐old female baby developed severe bronchopulmonary dysplasia with severe pulmonary hypertension, and she underwent extracorporeal membrane oxygenation for cardiac collapse and lung support. Then, we performed heart–lung transplantation to manage the irreversible deterioration of her lung function. After the heart‐lung transplantation, we found the radiological abnormalities persisted on follow‐up chest radiographs until the 13th postoperative day diagnosed as lung herniation of the right lower lobe on chest computed tomography.Results: After the relocation of the herniated lung, the clinical condition of the patient improved, and the patient is currently growing without any respiratory symptoms.Conclusions: In this case report, we emphasize that clinical awareness and high suspicion of this rare complication are needed for early diagnosis and proper treatment to prevent post‐transplantation morbidity and mortality related to potential ischemic injury.
- 20 November 2023
- Published by Wiley in Pediatric Transplantation
- Vol. 28 (1) , e14656
Right lower lung midline herniation as a rare complication in an infant with heart–lung transplantation: A case report
Background: Lung herniation is a rare complication of heart–lung transplantation that can be fatal owing to vascular compromise and airway obstruction. To date, only five cases of lung herniation related to heart–lung transplantation have been reported in the literature; however, to the best of our knowledge, this is the first worldwide report of heart–lung transplantation‐related lung herniation in an infant.Methods: We describe the case of lung herniation as a rare heart–lung transplantation‐related complication in an infant. A 12‐month‐old female baby developed severe bronchopulmonary dysplasia with severe pulmonary hypertension, and she underwent extracorporeal membrane oxygenation for cardiac collapse and lung support. Then, we performed heart–lung transplantation to manage the irreversible deterioration of her lung function. After the heart‐lung transplantation, we found the radiological abnormalities persisted on follow‐up chest radiographs until the 13th postoperative day diagnosed as lung herniation of the right lower lobe on chest computed tomography.Results: After the relocation of the herniated lung, the clinical condition of the patient improved, and the patient is currently growing without any respiratory symptoms.Conclusions: In this case report, we emphasize that clinical awareness and high suspicion of this rare complication are needed for early diagnosis and proper treatment to prevent post‐transplantation morbidity and mortality related to potential ischemic injury.
- 20 November 2023
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 34 (4) , 914-918
Extubation in operating room versus early extubation in ICU after open-heart surgery in patients with CHDs
Backgrounds and Objectives: The “Fast track” protocol is an early extubation strategy to reduce ventilator-associated complications and induce early recovery after open-heart surgery. This study compared clinical outcomes between operating room extubation and ICU extubation after open-heart surgery in patients with CHD.Methods: We retrospectively reviewed 215 patients who underwent open-heart surgery for CHDs under the scheduled “Fast track” protocol between September 2016 and April 2022. The clinical endpoints were post-operative complications, including bleeding, respiratory and neurological complications, and hospital/ICU stays.Results: The patients were divided into operating room extubation (group O, n = 124) and ICU extubation (group I, n=91) groups. The most frequently performed procedures were patch closures of the atrial septal (107/215, 49.8%) and ventricular septal (89/215, 41.4%) defects. There were no significant differences in major post-operative complications or ICU and hospital stay duration between the two groups; however, patients in group I showed longer mechanical ventilatory support (0.0 min vs. 59.0 min (interquartile range: 17.0–169.0), p < 0.001). Patients in Group O showed higher initial lactate levels (3.2 ± 1.7 mg/dL versus 2.5 ± 2.0 mg/dL, p = 0.007) and more frequently used additional sedatives and opioid analgesics (33.1% versus 19.8%, p = 0.031).Conclusions: Extubation in the operating room was not beneficial for patients during post-operative ICU or hospital stay. Early extubation in the ICU resulted in more stable hemodynamics in the immediate post-operative period and required less use of sedatives and analgesics.
- 20 November 2023
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 34 (4) , 914-918
Extubation in operating room versus early extubation in ICU after open-heart surgery in patients with CHDs
Backgrounds and Objectives: The “Fast track” protocol is an early extubation strategy to reduce ventilator-associated complications and induce early recovery after open-heart surgery. This study compared clinical outcomes between operating room extubation and ICU extubation after open-heart surgery in patients with CHD.Methods: We retrospectively reviewed 215 patients who underwent open-heart surgery for CHDs under the scheduled “Fast track” protocol between September 2016 and April 2022. The clinical endpoints were post-operative complications, including bleeding, respiratory and neurological complications, and hospital/ICU stays.Results: The patients were divided into operating room extubation (group O, n = 124) and ICU extubation (group I, n=91) groups. The most frequently performed procedures were patch closures of the atrial septal (107/215, 49.8%) and ventricular septal (89/215, 41.4%) defects. There were no significant differences in major post-operative complications or ICU and hospital stay duration between the two groups; however, patients in group I showed longer mechanical ventilatory support (0.0 min vs. 59.0 min (interquartile range: 17.0–169.0), p < 0.001). Patients in Group O showed higher initial lactate levels (3.2 ± 1.7 mg/dL versus 2.5 ± 2.0 mg/dL, p = 0.007) and more frequently used additional sedatives and opioid analgesics (33.1% versus 19.8%, p = 0.031).Conclusions: Extubation in the operating room was not beneficial for patients during post-operative ICU or hospital stay. Early extubation in the ICU resulted in more stable hemodynamics in the immediate post-operative period and required less use of sedatives and analgesics.
- Open Access
- 14 August 2023
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 56 (6) , 445-448
Valve-Sparing Neo-Aortic Root Replacement for Neo-Aortic Root Dilatation 20 Years after Arterial Switch Operation for Transposition of the Great Arteries: A Case Report
Sangjun Lee, M.D., Chan Hyeong Kim, M.D., Jae Hong Lee, M.D., Jae Gun Kwak, M.D., Ph.D.. J Chest Surg -0001;0:. https://doi.org/10.5090/jcs.23.051
- 14 August 2023
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 56 (6) , 445-448
Open AccessValve-Sparing Neo-Aortic Root Replacement for Neo-Aortic Root Dilatation 20 Years after Arterial Switch Operation for Transposition of the Great Arteries: A Case Report
Sangjun Lee, M.D., Chan Hyeong Kim, M.D., Jae Hong Lee, M.D., Jae Gun Kwak, M.D., Ph.D.. J Chest Surg -0001;0:. https://doi.org/10.5090/jcs.23.051
- Open Access
- 7 July 2022
- Published by Springer Nature in Research Square
Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer’s disease: associations with β-amyloid-PET, neurodegeneration and cognition
Glial fibrillary acidic protein (GFAP) is a promising candidate blood-based biomarker for Alzheimer’s disease (AD) diagnosis and prognostication. The timing of its disease-associated changes, its clinical correlates, and biofluid-type dependency will influence its clinical utility. We evaluated plasma, serum, and CSF GFAP in families with autosomal dominant AD (ADAD), leveraging the predictable age at symptom onset to determine changes by stage of disease. Plasma GFAP elevations appear a decade before expected symptom onset, after β-amyloid accumulation and prior to neurodegeneration and cognitive decline. Plasma GFAP distinguished β-amyloid-positive from β-amyloid-negative ADAD participants and showed a stronger relationship with β-amyloid load in asymptomatic than symptomatic ADAD. Higher plasma GFAP was associated with the degree and rate of neurodegeneration and cognitive impairment. Serum GFAP showed similar relationships, but these were less pronounced for CSF GFAP. Our findings support a role for plasma GFAP as a clinical biomarker for β-amyloid-associated cognitive deterioration in AD.
- 7 July 2022
- Published by Springer Nature in Research Square
Open AccessPlasma glial fibrillary acidic protein in autosomal dominant Alzheimer’s disease: associations with β-amyloid-PET, neurodegeneration and cognition
Glial fibrillary acidic protein (GFAP) is a promising candidate blood-based biomarker for Alzheimer’s disease (AD) diagnosis and prognostication. The timing of its disease-associated changes, its clinical correlates, and biofluid-type dependency will influence its clinical utility. We evaluated plasma, serum, and CSF GFAP in families with autosomal dominant AD (ADAD), leveraging the predictable age at symptom onset to determine changes by stage of disease. Plasma GFAP elevations appear a decade before expected symptom onset, after β-amyloid accumulation and prior to neurodegeneration and cognitive decline. Plasma GFAP distinguished β-amyloid-positive from β-amyloid-negative ADAD participants and showed a stronger relationship with β-amyloid load in asymptomatic than symptomatic ADAD. Higher plasma GFAP was associated with the degree and rate of neurodegeneration and cognitive impairment. Serum GFAP showed similar relationships, but these were less pronounced for CSF GFAP. Our findings support a role for plasma GFAP as a clinical biomarker for β-amyloid-associated cognitive deterioration in AD.